Artificial Intelligence Drug Discovery by Genesis Therapeutics
Genesis Therapeutics Secures $200M in Funding to Advance Artificial Intelligence drug Discovery for Alzheimer’s Disease Artificial Intelligence Drug Discovery : Genesis Therapeutics, a clinical-stage drug discovery company using artificial intelligence (AI) to design and develop new drugs, announced today that it has raised $200 million in a Series B funding round. The round was led … Read more